Get started
Author

Carla Ann Wijbrandts

Observed names: C A Wijbrandts, C. A. Wijbrandts, C.A. Wijbrandts, Carla A. Wijbrandts, Carla A Wijbrandts, Carla A. Wijbrandts, Carla Wijbrandts, Wijbrandts, C.A., Wijbrandts, Carla A
Institution: Reade
OpenAlex ID: A5090448389
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
2007 · Geertje M Bartelds, Carla A Wijbrandts, et al. · Annals of the Rheumatic Diseases · 562
Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response
2007 · R M Thurlings, K Vos, et al. · Annals of the Rheumatic Diseases · 334
PDF
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients
2007 · T C T M van der Pouw Kraan, C A Wijbrandts, et al. · Annals of the Rheumatic Diseases · 313
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study
2009 · G M Bartelds, C A Wijbrandts, et al. · Annals of the Rheumatic Diseases · 225
PDF
Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis
2007 · Koen Vos, Rogier M. Thurlings, et al. · Arthritis & Rheumatism · 194
Body mass index and clinical response to infliximab in rheumatoid arthritis
2010 · Ruth Klaasen, Carla A. Wijbrandts, et al. · Arthritis & Rheumatism · 188
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium
2007 · C A Wijbrandts, M G W Dijkgraaf, et al. · Annals of the Rheumatic Diseases · 154
PDF
MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis
2013 · Ivy Y Choi, Danielle M Gerlag, et al. · Annals of the Rheumatic Diseases · 153
Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss
2008 · C A Wijbrandts, R Klaasen, et al. · Annals of the Rheumatic Diseases · 151
PDF
Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment
2010 · Lisa GM van Baarsen, Carla A Wijbrandts, et al. · Arthritis Research & Therapy · 132
PDF
Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype
2008 · Rogier M. Thurlings, Carla A. Wijbrandts, et al. · Arthritis & Rheumatism · 123
PDF
Venous and arterial thromboembolic events in adalimumab‐treated patients with antiadalimumab antibodies: A case series and cohort study
2011 · L. A. Korswagen, G. M. Bartelds, et al. · Arthritis & Rheumatism · 121
Prediction of Response to Targeted Treatment in Rheumatoid Arthritis
2017 · C.A. Wijbrandts, P.P. Tak · Mayo Clinic Proceedings · 117
Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker
2007 · Carla A. Wijbrandts, Clarissa E. Vergunst, et al. · Arthritis & Rheumatism · 113
Responsiveness to anti-tumour necrosis factor α therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients
2007 · T C van der Pouw Kraan, C A Wijbrandts, et al. · Annals of the Rheumatic Diseases · 95
The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis
2010 · Johan Lindberg, Carla A. Wijbrandts, et al. · PLoS ONE · 94
PDF
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
2009 · Ruth Klaasen, Rogier M. Thurlings, et al. · Arthritis & Rheumatism · 94
Synovial tissue heterogeneity in rheumatoid arthritis in relation to disease activity and biomarkers in peripheral blood
2010 · Lisa G. M. van Baarsen, Carla A. Wijbrandts, et al. · Arthritis & Rheumatism · 79
Anti‐adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin‐10 gene polymorphisms
2009 · G. M. Bartelds, C. A. Wijbrandts, et al. · Arthritis & Rheumatism · 79
Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets
2011 · Daphne de Launay, Marleen GH van de Sande, et al. · Annals of the Rheumatic Diseases · 75
PDF
Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study
2010 · Geertje M Bartelds, Els de Groot, et al. · Arthritis Research & Therapy · 71
PDF
Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers.
2007 · Barry Bresnihan, Danielle M Gerlag, et al. · PubMed · 69
Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis
2008 · C A Wijbrandts, S I van Leuven, et al. · Annals of the Rheumatic Diseases · 68
PDF
Anti-TNF Therapy Reduces Serum Levels of Chemerin in Rheumatoid Arthritis: A New Mechanism by Which Anti-TNF Might Reduce Inflammation
2013 · Marieke M. J. Herenius, Ana S. F. Oliveira, et al. · PLoS ONE · 67
PDF
The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study
2011 · R. Klaasen, T. Cantaert, et al. · Lara D. Veeken · 65
Works count: 95
Citation count: 4,570
H-index: 37
I10-index: 46
Year
Topic
Type